The aim of this study was to investigate the expression patterns and clinicopathological implications of fibulin-5 in NPC progression, and to identify potential underlying molecular mechanisms that may lead to an increased understanding of NPC. The gene discussed is FBLN5; the disease is nasopharyngeal carcinoma.